Ruxolitinib and Steroid As First Line Therapy for Acute GVHD

NCT03701698 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Participants recruitment failure

Conditions

Acute GVHD

Interventions

DRUG: Ruxolitinib Oral Tablet
DRUG: Methylprednisolone

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine